Rapid Resolution of Erosive Psoriatic Juvenile Idiopathic Arthritis With Anti-Tumor Necrosis Factor Therapy

被引：0
|
作者：
Felix, Mario David [1 ]
Ostrov, Barbara E. [2 ]
机构：
[1] Albany Med Coll, Bernard & Millie Duker Childrens Hosp, Dept Pediat, Internal Med Pediat Program, Albany, NY 12208 USA
[2] Albany Med Coll, Bernard & Millie Duker Childrens Hosp, Dept Pediat, Div Pediat Rheumatol, Albany, NY 12208 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷 / 8S期
关键词：
D O I：
10.1097/RHU.0000000000001602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S688 / S689
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes After Withdrawal of Anti-Tumor Necrosis Factor α Therapy in Patients With Juvenile Idiopathic Arthritis: A Twelve-Year Experience
    Baszis, Kevin
    Garbutt, Jane
    Toib, Dana
    Mao, Jingnan
    King, Allison
    White, Andrew
    French, Anthony
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3163 - 3168
  • [22] PERSISTENCE WITH ANTI-TUMOR NECROSIS FACTOR THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN ROUTINE PRACTICE
    Morel, J.
    Combe, B.
    Daien, C.
    Lukas, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 867 - 867
  • [23] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Rudwaleit, Martin
    Van den Bosch, Filip
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [24] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Martin Rudwaleit
    Filip Van den Bosch
    Martina Kron
    Sonja Kary
    Hartmut Kupper
    Arthritis Research & Therapy, 12
  • [25] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [26] A case report of intracranial hypertension and aseptic meningitis: anti-tumor necrosis factor associated or juvenile idiopathic arthritis related
    Akca, Ummusen Kaya
    Sokmen, Okan
    Bolek, Ertugrul Cagri
    Demir, Selcan
    Kilic, Levent
    Cevik, Isin Unal
    Bilginer, Yelda
    TURKISH JOURNAL OF PEDIATRICS, 2021, 63 (03) : 522 - 526
  • [27] Therapeutic effects of the anti-tumor necrosis factor monoclonal antibody, infliximab, in four children with refractory juvenile idiopathic arthritis
    Norambuena, X.
    Mallol, J.
    Rios, G.
    Quevedo, F.
    Quezada, A.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2007, 35 (02) : 52 - 56
  • [28] Association of persistence with anti-tumor necrosis factor (anti-TNF) therapy and healthcare costs in patients with psoriatic arthritis (PSA)
    Tang, Boxiong
    Meissner, B.
    Dabbous, Omar
    Rahman, Mirza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB122 - AB122
  • [29] Hodgkin's lymphoma associated with anti-tumor necrosis factor use in juvenile idiopathic arthritis: Supplemental case report
    Imundo, Lisa
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (08) : 1681 - 1682
  • [30] Association of persistence with anti-tumor necrosis factor (anti-TNF) therapy and health care costs in patients with psoriatic arthritis
    Tang, B.
    Rahman, M., I
    Meissner, B.
    Dabbous, O.
    Naim, A.
    Thompson, H. C.
    VALUE IN HEALTH, 2007, 10 (06) : A250 - A251
12345